OLIGOMERIX To Present At Biotech Showcase™ 2014  
1/7/2014 8:41:47 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

NEW YORK, Jan. 7, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today that James Moe, PhD, President & CEO, will be presenting at the Biotech Showcase 2014 Conference.

Details of Oligomerix's presentation are as follows:


Biotech Showcase 2014 Conference


January 14, 2104


9:15 a.m. PT


Room B - Mission I (4th Floor): Parc 55 Wyndham San Francisco, CA

Oligomerix, Inc. is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The Company was founded in 2006 and is headquartered at Audubon Biomedical Science and Technology Park at Columbia University Medical Center and is carrying out its in vivo studies at New York Medical College. The Company is seeking strategic partners to help accelerate these exciting programs. For more information, visit

Certain matters described in this news release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on market growth, competition and dependence on government agencies and other third parties for funding contract research and services.



Jack Pasini

Chief Commercial Officer

Oligomerix, Inc


Tiberend Strategic Advisors, Inc.

Andrew Mielach


SOURCE Oligomerix, Inc.

Help employers find you! Check out all the jobs and post your resume.